Skip to main content
BLSM filings

Corporate insider profile

John P. Schmid Filing Activity

Latest reported as Director of BlossomHill Therapeutics, Inc. (BLSM).

Purchase filings
1
Reported companies
1
Net open-market value
$96,000
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026BlossomHill Therapeutics, Inc. (BLSM)DirectorOpen Market Purchase6,000$16.00$96,000